Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans

BMC Health Services Research
Elizabeth E RougheadAndrew L Gilbert

Abstract

The Australian Government Department of Veterans' Affairs (DVA) funds an ongoing health promotion based program to improve use of medicines and related health services, which implements interventions that include audit and feedback in the form of patient-specific feedback generated from administrative claims records. We aimed to determine changes in medicine use as a result of the program. The program provides targeted patient-specific feedback to medical practitioners. The feedback is supported with educational material developed by a clinical panel, subject to peer review and overseen by a national editorial committee. Veterans who meet target criteria also receive educational brochures. The program is supported by a national call centre and ongoing national consultation. Segmented regression analyses (interrupted time series) were undertaken to assess changes in medication use in targeted veterans pre and post each intervention. 12 interventions were included; three to increase medicine use, seven which aimed to reduce use, and two which had combination of messages to change use. All programs that aimed to increase medicine use were effective, with relative effect sizes at the time of the intervention ranging from 1% to 8%. ...Continue Reading

References

Sep 1, 1989·The American Psychologist·A Bandura
Jan 1, 1995·International Journal of Technology Assessment in Health Care
Jan 1, 1994·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·J O ProchaskaD Rosenbloom
Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·A K WagnerD Ross-Degnan
Mar 5, 2004·Pharmacoepidemiology and Drug Safety·E E RougheadA L Gilbert
Apr 21, 2006·The Cochrane Database of Systematic Reviews·G JamtvedtA D Oxman
Dec 22, 2007·Pharmacoepidemiology and Drug Safety·John A MandrykLynn M Weekes
Oct 8, 2008·BMJ : British Medical Journal·Peter J PronovostDale M Needham
Feb 11, 2009·The Medical Journal of Australia·Elizabeth E RougheadAndrew L Gilbert
Dec 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Elizabeth E Roughead

❮ Previous
Next ❯

Citations

Jan 31, 2016·International Journal of Clinical Pharmacy·Ines Krass
Mar 26, 2014·British Journal of Clinical Pharmacology·Emily ReeveMichael D Wiese
Sep 4, 2018·The Cochrane Database of Systematic Reviews·Audrey RankinCarmel Hughes
Aug 17, 2018·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Jodie B HillenGillian E Caughey
Dec 7, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Nicole L PrattElizabeth E Roughead
Aug 11, 2018·BMC Health Services Research·Lisa M Kalisch EllettElizabeth E Roughead
Jan 1, 2019·Current Epidemiology Reports·Nicole Pratt, Elizabeth Roughead
May 22, 2020·Australasian Journal on Ageing·Lisa M Kalisch EllettElizabeth E Roughead

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here